Clinical significance of unfavorable findings in intermediate‐risk prostate cancer patients for predicting treatment outcomes after contemporary, dose‐escalated multimodal radiotherapyFumihiko Urabe, Shin Egawa, Kojiro Tashiro et al.|The Prostate|2021Cited by 5
Long‐term outcomes of radical prostatectomy versus low‐dose‐rate brachytherapy in patients with intermediate‐risk prostate cancer: Propensity score matched comparisonFumihiko Urabe, Shin Egawa, Kenta Miki et al.|The Prostate|2022Cited by 3